ip地址开头255是_zuciwang.com:1999-12-31 · IP地址由四组三位数据和点组成的，每个 San 位数字值必须在0~255之间，也就还0.0.0.0~255.255.255.255 Zhi 间，只要IP必须在这个IP段里，但是255.255.255.255 Shi 广播地址一般是不使用的，另外有些地址是 Bu 使用的例如192.168.1.1这样的 Yi 般为路由

CTL-MAT offers reliable, quantitative, nonanimal-based pyrogen testing solutions using the Monocyte Activation Test.

Our products and services permit Ph. Eur. 2.6.30-compliant, robust and accurate detection of pyrogenic contaminants in parenteral drugs, biopharmaceuticals, cosmetics and solid medical devices.

CTL-MAT can support its customers with all their MAT related needs.

Contact us 

CTL-MAT, LLC was founded by Drs. Shabnam Solati and Dr. Prof. Paul Lehmann.

Drs Solati serves as CEO. She has over 14 years of Monocyte Activation Test experience with both the scientific and regulatory aspects of the technology.

Dr Lehmann is the CSO of CTL-MAT and is also the founder and CEO of Cellular Technology Limited.

Cellular Technology Limited has been the pioneer and industry leader in the development, use, and manufacturing of standardized tools for cellular immune assays. CTL’s founding scientists were the first to introduce protocols for functionality loss free cryopreservation of PBMC (patent). For over 20 years, CTL has been a leading provider of cryopreserved PBMC and cytokine detection kits. 

CTL-MAT, combines CTL’s background in immune monitoring with Drs. Solati’s MAT specific expertise to support the global adaption of the Monocyte Activation Test.

CTL-MAT offers products and services for the complete integration of the Monocyte Activation Test. The MAT permits European Pharmacopoeia 2.6.30 compliant, robust and accurate detection of pyrogenic contaminants of parenteral drugs, biopharmaceuticals and solid medical devices.

CTL-MAT’s mission is to enable reliable and ethical drug releases thus reducing unnecessary animal-based testing.

GHP announces CTL winner of 2018 Technology Award: "Best Cellular Immune Assays Manufacturing Company 2018 & Leading Provider of Elispot & FluoroSpot Assays 2018"